Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
3.66Price to Book
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 220.63M | $ 806.96M | 3.66 |
| 3/31/2025 | $ 114.89M | $ 756.92M | 6.59 |
| 12/31/2024 | $ 84.66M | $ 478.43M | 5.65 |
| 9/30/2024 | $ 58.71M | $ 609.81M | 10.39 |
| 6/30/2024 | $ 46.18M | $ 274.83M | 5.95 |
| 3/31/2024 | $ 58.01M | $ 297.33M | 5.13 |
| 12/31/2023 | $ 70.14M | $ 188.04M | 2.68 |
| 9/30/2023 | $ 83.2M | $ 171.56M | 2.06 |
| 6/30/2023 | $ 49.05M | $ 242.24M | 4.94 |
| 3/31/2023 | $ 53.93M | $ 233.7M | 4.33 |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) P/B stands at 5.02.
- Over the past 5 years, CORMEDIX INC's average P/B has been 4.35.
- The median P/B for CORMEDIX INC during this period was 3.62
- CORMEDIX INC reached its highest P/B over the past 5 years at 10.39.
- The lowest P/B recorded by CORMEDIX INC in the same timeframe 1.95
CORMEDIX INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for CORMEDIX INC is calculated as follows: Market Cap [ $ 172.87M ] / Equity [ $ 34.47M ]
(=) P/B [ 5.02 ] CRMD - Price to Book, Last 5 years
1.95
Minimum
Mar 31, 2022
10.39
Maximum
Sep 30, 2024
4.35
Average
3.62
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.29 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.29 |
| median | 1.63 |
| std | 1.81 |